| 1） |
Toda K：Treatment of chronic widespread pain is similar to treatment of fibromyalgia
throughout the world．J Musculoskelet Pain 2010；18：317-318． |
| 2） |
戸田克広：線維筋痛症がわかる本．主婦の友社，2010． |
| 3） |
Nishishinya B，Urrutia G，Walitt B，et al：Amitriptyline in the treatment of fibromyalgia：a
systematic review of its efficacy．Rheumatology（Oxford） 2008；47：1741-1746． |
| 4） |
Heymann RE，Helfenstein M，Feldman D：A double-blind，randomized，controlled study
of amitriptyline，nortriptyline and placebo in patients with fibromyalgia．An analysis of
outcome measures．Clin Exp Rheumatol 2001；19：697-702． |
| 5） |
戸田克広：線維筋痛症と脳脊髄液減少症を合併した1例．広島医学 2006；59：460-463． |
| 6） |
Wysenbeek AJ，Mor F，Lurie Y，et al：Imipramine for the treatment of fibrositis：a
therapeutic trial．Ann Rheum Dis 1985；44：752-753． |
| 7） |
Bibolotti E，Borghi C，Pasculli E，et al：The management of fibrositis A double-blind
comparisonof maprotilline（Ludiomil），chlomipramine and placebo．Clinical Trials
Journal 1986；23：269-280． |
| 8） |
山下 真，芦原 睦：線維筋痛症に対するClomipramine点滴療法の適応と有効性．日本線維筋痛症学会第2回学術集会プログラム抄録集．2010；45． |
| 9） |
Häuser W，Petzke F，Sommer C：Comparative efficacy and harms of duloxetine，
milnacipran，and pregabalin in fibromyalgia syndrome．J Pain 2010；11：505-521． |
| 10） |
Patkar AA，Masand PS，Krulewicz S，et al：A randomized，controlled，trial of controlled
release paroxetine in fibromyalgia．Am J Med 2007；120：448-454． |
| 11） |
Pae CU，Masand PS，Marks DM，et al：History of early abuse as a predictor of treatment
response in patients with fibromyalgia：A post-hoc analysis of a 12-week，randomized，
double-blind，placebo-controlled trial of paroxetine controlled release．World J Biol
Psychiatry 2009；10（4 Pt 2）：435-441． |
| 12） |
Morillas-Arques P，Rodriguez-Lopez CM，Molina-Barea R，et al：Trazodone for the
treatment of fibromyalgia：an open-label，12-week study．BMC Musculoskelet Disord
2010；11：204． |
| 13） |
Straube S，Derry S，Moore RA，et al：Pregabalin in fibromyalgia：meta-analysis of efficacy
and safety from company clinical trial reports．Rheumatology（Oxford） 2010；49：706-
715． |
| 14） |
Toda K：Comparison of efficacy between neurotropin and amitriptyline in fibromyalgia．
Abstracts of the12th world congress on pain 2008；PT181． |
| 15） |
Toda K：Efficacy of lafutidine for fibromyalgia．Abstracts of the13th world congress on
pain 2010；PW 380． |
| 16） |
Drewes AM，Andreasen A，Jennum P，et al：Zopiclone in the treatment of sleep
abnormalities in fibromyalgia．Scand J Rheumatol 1991；20：288-293． |
| 17） |
Gronblad M，Nykanen J，Konttinen Y，et al：Effect of zopiclone on sleep quality，morning
stiffness，widespread tenderness and pain and general discomfort in primary
fibromyalgia patients．A double-blind randomized trial．Clin Rheumatol 1993；12：186-
191． |
| 18） |
Moldofsky H，Lue FA，Mously C，et al：The effect of zolpidem in patients with
fibromyalgia：a dose ranging，double blind，placebo controlled，modified crossover
study．J Rheumatol 1996；23：529-533． |
| 19） |
Pramipexole ER vs Placebo in Fibromyalgia：http://www.clinicaltrials.gov/ct2/show/NCT00689052 2011年3月31日確認 |
| 20） |
Holman AJ：Ropinirole，open preliminary observations of a dopamine agonist for
refractory fibromyalgia．J Clin Rheumatol 2003；9：277-279． |
| 21） |
Holman AJ：Treatment of fibromyalgia with the dopamine agonist ropinirole：a 14-week
double-blind randomized controlled trial（RCT）with 14-week blinded extension．
Arthritis Rheum 2004；50：S698． |
| 22） |
Singh G：Recent considerations in nonsteroidal anti-inflammatory drug gastropathy．
Am J Med 1998；105：31S-38S． |
| 23） |
Rico-Villademoros F，Hidalgo J，Morillas-Arques P，et al：An open-label study of
levopromazine（methotrimeprazine）as an add-on therapy in fibromyalgia
management．Clin Exp Rheumatol 2009；27：S16-20． |
| 24） |
Ali A，Njike VY，Northrup V，et al：Intravenous Micronutrient Therapy（Myers' Cocktail）
for Fibromyalgia：A Placebo-Controlled Pilot Study．J Altern Complement Med 2009；
15：247-257． |
| 25） |
三木健司，行岡正雄，浦野房三，他：慢性疼痛疾患：線維筋痛症とリウマチ性脊椎関節炎の治療反応の相違．日本脊椎関節炎研究会誌2010；2：79-87． |
| 26） |
Bennett RM，Clark SC，Walczyk J：A randomized，double-blind，placebo-controlled
study of growth hormone in the treatment of fibromyalgia．Am J Med 1998；104：227-
231． |
| 27） |
Sorensen J，Bengtsson A，Backman E，et al：Pain analysis in patients with fibromyalgia．
Effects of intravenous morphine，lidocaine，and ketamine．Scand J Rheumatol 1995；
24：360-365． |
| 28） |
Guedj E，Cammilleri S，Colavolpe C，et al：Follow-up of pain processing recovery after
ketamine in hyperalgesic fibromyalgia patients using brain perfusion ECD-SPECT．Eur J
Nucl Med Mol Imaging 2007；34：2115-2119． |
| 29） |
Lee SS，Kim SH，Nah SS，et al：Smoking habits influence pain and functional and
psychiatric features in fibromyalgia．Joint Bone Spine 2010；Epub ahead of print． |
| 30） |
McNally JD，Matheson DA，Bakowsky VS．The epidemiology of self-reported
fibromyalgia in Canada．Chronic Dis Can 2006；27：9-16． |
| 31） |
Shapiro JR，Anderson DA，Danoff-Burg S：A pilot study of the effects of behavioral
weight loss treatment on fibromyalgia symptoms．J Psychosom Res 2005；59：275-
282． |
| 32） |
Ciappuccini R, Ansemant T, Maillefert JF, et al: Aspartame-induced fibromyalgia, an
unusual but curable cause of chronic pain. Clin Exp Rheumatol 2010; 28: S131-133. |
|
戸田克広
|
新検索ページはこちら
ログイン
お問い合わせ
書誌情報
